| Nicotine | IC50 | 430.0 [1], 1000.0 [2], 10000.0 [3] |
| Nicotine | Ki | 530.0 [1] |
| Cytisine | Ki | 840.0 [1] |
| Bupropion | IC50 | 1.8 [1], 1800.0 [2] |
| Varenicline | IC50 | 110.0 [1], 1000.0 [2] |
| Varenicline | Ki | 74.7 [1], 86.0 [2] |
| Epibatidine | Ki | 0.15 [1], 0.19 [2], 0.22 [3], 0.46 [4] |
| Mecamylamine | IC50 | 100.0 [1], 700.0 [2], 3400.0 [3] |
| Piperidine, 1-(3,3-diphenylallyl)- | IC50 | 100.0 [1], 380.0 [2] |
| Piperidine, 1-(3,3-diphenylallyl)- | Ki | 2200.0 [1] |
| 3-Benzhydrylquinuclidine | IC50 | 200.0 [1], 400.0 [2] |
| 3-Benzhydrylquinuclidine | Ki | 1500.0 [1] |
| 3-Benzhydryl-1-benzyl-1-azoniabicyclo[2.2.2]octane | IC50 | 80.0 [1], 600.0 [2] |
| 3-Benzhydryl-1-benzyl-1-azoniabicyclo[2.2.2]octane | Ki | 2300.0 [1] |
| Tubocurarine chloride | IC50 | 2000.0 [1], 6800.0 [2] |
| 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine | IC50 | 10000.0 [1] |
| 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine | Ki | 390.0 [1] |
| Methyllycaconitine | IC50 | 1000.0 [1], 2600.0 [2] |
| 3-(2,4-Dimethoxybenzylidene)anabaseine | Ki | 2500.0 [1] |
| Benzamide, N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chloro- | IC50 | 60000.0 [1] |
| Benzamide, N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chloro- | Ki | 60000.0 [1] |
| Sazetidine A | IC50 | 10000.0 [1] |
| Sazetidine A | Ki | 1900.0 [1] |
| Radafaxine | IC50 | 3300.0 [1], 6500.0 [2] |
| N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide | IC50 | 100000.0 [1] |
| 4-[(E)-5,6-Dihydro-2,3'-bipyridin-3(4H)-ylidenemethyl]-3-methoxyphenol | Ki | 970.0 [1] |
| N-(2-Fluorophenyl)-2-{4-[(4-fluorophenyl)sulfonyl]piperazin-1-yl}acetamide | IC50 | 9000.0 [1], 19600.0 [2] |
| 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane | Ki | 10000.0 [1] |
| Biphenyl-2-carboxylic acid 1-(3-phenyl-propyl)-piperidin-3-ylmethyl ester | IC50 | 1700.0 [1], 100000.0 [2] |
| 3-Benzylidenequinuclidine | IC50 | 6000.0 [1] |
| 3-Benzylidenequinuclidine | Ki | 2100.0 [1] |
| 3-[(Z)-(3-Pyridyl)methylene]-1-azabicyclo[2.2.2]octane | IC50 | 10000.0 [1] |
| 3-[(Z)-(3-Pyridyl)methylene]-1-azabicyclo[2.2.2]octane | Ki | 1600.0 [1] |
| 4-Methoxy-3-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]phenol | Ki | 271.0 [1] |
| 3-[(1R)-1-[(2S)-1-Methylpyrrolidin-2-yl]ethoxy]phenol | Ki | 257.0 [1] |
| Cyclopropyl(3,7-diazabicyclo[3.3.1]nonan-3-yl)methanone | Ki | 110.0 [1] |
| 2,3,3a,4,6,6a-Hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl(cyclopropyl)methanone | Ki | 670.0 [1] |
| 2-Acetylamino-benzoic acid 1-(3-phenyl-propyl)-piperidin-3-ylmethyl ester | IC50 | 4265.8 [1], 8400.0 [2] |
| 2-Trifluoromethyl-benzoic acid 1-(3-phenyl-propyl)-piperidin-3-ylmethyl ester | IC50 | 3200.0 [1], 5500.0 [2] |
| [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(1,3-dioxoisoindol-2-yl)benzoate | IC50 | 1300.0 [1], 5888.44 [2] |
| Biphenyl-4-carboxylic acid 1-(3-phenyl-propyl)-piperidin-3-ylmethyl ester | IC50 | 3000.0 [1], 18620.87 [2] |
| [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(3,3-dimethyl-2,5-dioxopyrrolidin-1-yl)benzoate | IC50 | 5011.87 [1], 7500.0 [2] |
| 2-Methoxy-benzoic acid 1-(3-phenyl-propyl)-piperidin-3-ylmethyl ester | IC50 | 3200.0 [1], 12022.64 [2] |
| 2-Chloro-benzoic acid 1-(3-phenyl-propyl)-piperidin-3-ylmethyl ester | IC50 | 3400.0 [1], 22908.68 [2] |
| (2S,3S)-2-(3-Fluorophenyl)-3,5,5-trimethylmorpholin-2-ol | IC50 | 5600.0 [1], 15000.0 [2] |
| (2S,3S)-2-(3-Bromophenyl)-3,5,5-trimethylmorpholin-2-ol | IC50 | 1400.0 [1], 3200.0 [2] |
| (2S,3S)-2-(3-Chlorophenyl)-3-ethyl-5,5-dimethylmorpholin-2-ol | IC50 | 4300.0 [1], 5600.0 [2] |
| (2S,3S)-2-(3-Chlorophenyl)-5,5-dimethyl-3-propyl-morpholin-2-ol | IC50 | 3100.0 [1], 4800.0 [2] |
| (2S,3S)-2-(3-Chlorophenyl)-3,4,5,5-tetramethylmorpholin-2-ol | IC50 | 2800.0 [1], 6500.0 [2] |
| 1-Benzhydryl-4-aza-1-azoniabicyclo[2.2.2]octane | IC50 | 15000.0 [1] |
| 1-Benzhydryl-4-aza-1-azoniabicyclo[2.2.2]octane | Ki | 8500.0 [1] |
| (R,R)-Hydroxy Bupropion | IC50 | 1600.0 [1], 11000.0 [2] |
| (R)-2-((2S)-1-Methyl-2-pyrrolidinyl)-1,4-benzodioxane | IC50 | 2780.0 [1] |
| (R)-2-((2S)-1-Methyl-2-pyrrolidinyl)-1,4-benzodioxane | Ki | 1200.0 [1] |
| 3-[[(2S)-Azetidin-2-yl]methoxy]-5-hex-1-ynyl-2-methylpyridine | IC50 | 10000.0 [1] |
| 3-[[(2S)-Azetidin-2-yl]methoxy]-5-hex-1-ynyl-2-methylpyridine | Ki | 230000.0 [1] |
| 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(6-fluorohex-1-ynyl)-2-methylpyridine | IC50 | 10000.0 [1] |
| 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(6-fluorohex-1-ynyl)-2-methylpyridine | Ki | 130000.0 [1] |
| 6-[5-[[(2S)-Azetidin-2-yl]methoxy]-6-methylpyridin-3-yl]hex-5-yn-1-ol | IC50 | 50000.0 [1] |
| 6-[5-[[(2S)-Azetidin-2-yl]methoxy]-6-methylpyridin-3-yl]hex-5-yn-1-ol | Ki | 250000.0 [1] |
| 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(6-chlorohex-1-ynyl)-2-methylpyridine | IC50 | 10000.0 [1] |
| 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(6-chlorohex-1-ynyl)-2-methylpyridine | Ki | 86000.0 [1] |
| 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(2-cyclopropylethynyl)-2-methylpyridine | IC50 | 10000.0 [1] |
| 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(2-cyclopropylethynyl)-2-methylpyridine | Ki | 150000.0 [1] |
| 5-Hex-1-ynyl-2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine | IC50 | 6400.0 [1] |
| 5-Hex-1-ynyl-2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine | Ki | 94000.0 [1] |
| 2-(1-Azabicyclo[2.2.2]octan-3-yl)-2-phenylacetonitrile | IC50 | 23000.0 [1] |
| 2-(1-Azabicyclo[2.2.2]octan-3-yl)-2-phenylacetonitrile | Ki | 2100.0 [1] |
| Ondansetron | IC50 | 27000.0 [1] |
| Tropisetron | IC50 | 1800.0 [1] |
| Decamethonium | IC50 | 1700.0 [1] |
| Benzamide, N-(3R)-1-azabicyclo(2.2.2)oct-3-yl-4-chloro-, monohydrochloride | IC50 | 60000.0 [1] |
| Polygodial | IC50 | 48200.0 [1] |
| alpha-Methyltryptamine | Ki | 10000.0 [1] |
| Rivanicline | Ki | 5400.0 [1] |
| 18-Methoxycoronaridine | Ki | 700.0 [1] |
| (5S)-Spiro[1,3-oxazolidine-5,3'-1-azabicyclo[2.2.2]octane]-2-one | IC50 | 1000000.0 [1] |
| Anabaseine | Ki | 107.0 [1] |
| CID 9823180 | Ki | 7000.0 [1] |
| N,N-Diallyl-5-methoxytryptamine | Ki | 10000.0 [1] |
| 4-(6-Fluoro-5,5-dioxido-3-dibenzothienyl)-1,4-diazabicyclo(3.2.2)nonane | Ki | 709.0 [1] |
| 3-Bromocytisine | IC50 | 15.6 [1] |
| (S)-1-(2-Fluorophenyl)ethyl (S)-quinuclidin-3-ylcarbamate | IC50 | 19952.62 [1] |
| (1R,2R,4S)-N,2,3,3-Tetramethylbicyclo[2.2.1]heptan-2-amine | IC50 | 50.0 [1] |
| Cinnamolide | IC50 | 2620.0 [1] |
| Phantasmidine | Ki | 390.0 [1] |
| 2-(4-Morpholinyl)-5-[(2-thienylmethyl)amino]benzoic acid | IC50 | 100000.0 [1] |
| Rac-7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane | Ki | 1200.0 [1] |
| Dendocarbin A | IC50 | 100000.0 [1] |
| 1,4-Diazabicyclo(3.2.2)nonane, 4-(5-methyloxazolo(4,5-b)pyridin-2-yl)- | Ki | 5370.0 [1] |
| A-582941 Free base | Ki | 4700.0 [1] |
| 1,5-Methano-1H-3-benzazepine, 2,3,4,5-tetrahydro- | Ki | 2850.0 [1] |
| 3-(3-Pyridinyl)-3,7-diazabicyclo[3.3.1]nonane | Ki | 6.6 [1] |
| CID 10107234 | IC50 | 100000.0 [1] |
| N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-1-benzofuran-6-carboxamide | IC50 | 81000.0 [1] |
| N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-1-benzothiophene-6-carboxamide | IC50 | 38000.0 [1] |
| 2-(Tert-butyl(methyl)amino)-1-(3-chlorophenyl)propan-1-one | IC50 | 1.2 [1] |
| 2-(Tert-butylamino)-1-(3-fluorophenyl)propan-1-one | IC50 | 4.4 [1] |
| 4-Allyloxy-N-pyridin-2-yl-benzamide | IC50 | 61400.0 [1] |
| Laburnamine | Ki | 37000.0 [1] |